Insulin resistance, a hallmark of T2DM and obesity, is a clinical condition characterized by the impaired responsiveness of insulin-sensitive tissues to insulin and a compensatory increase in insulin release by β-cells [45]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.